If you or a loved one has diffuse large B-cell lymphoma (DLBCL) that is no longer responding to treatment or came back after treatment, chimeric antigen receptor (CAR) T-cell therapy may be an option.

For example, the Leukemia & Lymphoma Society’s Susan Lang Pre CAR T-Cell Therapy Travel Assistance Program offers $2,500 to cover treatment-related travel and lodging expenses such as ...

Medics took a biopsy of the growth and found it was Hodgkin lymphoma - a deadly type of blood cancer. Around 2,100 people are diagnosed with Hodgkin lymphoma in the UK each year. It is an uncommon ...

This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

Dance Moms star Abby Lee Miller has revealed she is not extending her support to her cancer-stricken former castmate Kelly Hyland. Kelly's daughters Paige and Brooke were Abby's dance students on ...

In a small number of cases, patients with CLL will develop lymphoma, a complication known as Richter transformation (RT). “It’s like having two cancers at once,” said Adam Kittai ...

He lost a year-long battle with lymphoma. Martindale, who brought joy to millions through shows like ‘Tic-Tac-Dough’ and ‘Gambit,’ died peacefully at his home in Rancho Mirage, California ...

In this 3-year updated analysis, the ORR was 77.8%, with 60.0% of patients achieving a CR with mosunetuzumab. Updated results from the pivotal phase 1/2 trial of mosunetuzumab in patients with ...

DLBCL is an aggressive (fast-growing) type of lymphoma and is one of the most prevalent types of blood cancer among adults. In Europe, an estimated 38,000 people are diagnosed with DLBCL each year.

diffuse large B-cell lymphoma (DLBCL) not otherwise specified who are ineligible for autologous stem cell transplant (ASCT). With this approval, this Columvi combination is the first bispecific ...